Aura Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 02/13/2026 | 6.92 M | $37.73 M | 0.00% | 10.50% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 5.10 M | $27.80 M | 0.00% | 7.73% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 4.88 M | $26.60 M | 0.00% | 7.40% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/17/2026 | 4.62 M | $25.18 M | 0.00% | 7.01% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 4.37 M | $23.83 M | 0.00% | 6.63% |
| BLACKROCK, INC. | 02/12/2026 | 3.56 M | $19.40 M | 4.55% | 5.40% |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2026 | 3.04 M | $16.57 M | 0.00% | 4.61% |
| VANGUARD GROUP INC | 01/29/2026 | 2.94 M | $16.00 M | 1.59% | 4.45% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.20 M | $11.98 M | -0.02% | 3.33% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 2.12 M | $11.54 M | 0.00% | 3.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.26 M | $6.85 M | -0.20% | 1.90% |
| LEVIN CAPITAL STRATEGIES, L.P. | 01/30/2026 | 1.04 M | $5.64 M | -36.36% | 1.57% |
| STATE STREET CORP | 02/13/2026 | 926.53 K | $5.05 M | 5.42% | 1.41% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 617.34 K | $3.36 M | 233.30% | 0.94% |
| ACORN CAPITAL ADVISORS, LLC | 02/17/2026 | 595.74 K | $3.25 M | 0.00% | 0.90% |
| B GROUP, INC. | 02/17/2026 | 572.58 K | $3.12 M | 0.00% | 0.87% |
| REGENCY CAPITAL MANAGEMENT INC.\DE | 02/11/2026 | 538.58 K | $2.94 M | -12.10% | 0.82% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 517.92 K | $2.82 M | 4.15% | 0.79% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 442.79 K | $2.42 M | -7.99% | 0.67% |
| NORTHERN TRUST CORP | 02/17/2026 | 412.81 K | $2.25 M | -4.80% | 0.63% |
| DECHENG CAPITAL LLC | 02/12/2026 | 360.48 K | $1.96 M | -30.08% | 0.55% |
| MORGAN STANLEY | 02/13/2026 | 218.41 K | $1.19 M | 22.35% | 0.33% |
| UBS GROUP AG | 01/29/2026 | 171.64 K | $935.43 K | -80.86% | 0.26% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 165.19 K | $900.26 K | 356.53% | 0.25% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 145.20 K | $791.34 K | 48.76% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 140.96 K | $768.23 K | 10.72% | 0.21% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 139.93 K | $762.60 K | -28.22% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 135.06 K | $736.09 K | 0.09% | 0.20% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 114.61 K | $624.62 K | 255.82% | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 02/13/2026 | 111.87 K | $609.66 K | -17.38% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 107.92 K | $588.18 K | 12.73% | 0.16% |
| RESOLUTE CAPITAL ASSET PARTNERS LLC | 02/17/2026 | 91.01 K | $495.98 K | 0.00% | 0.14% |
| PERMANENT CAPITAL MANAGEMENT, LP | 01/07/2026 | 75.86 K | $413.46 K | -48.66% | 0.12% |
| NUVEEN, LLC | 02/12/2026 | 72.33 K | $394.22 K | 0.00% | 0.11% |
| BARCLAYS PLC | 02/13/2026 | 69.30 K | $377.67 K | 6.72% | 0.11% |
| CITADEL ADVISORS LLC | 02/17/2026 | 68.55 K | $373.59 K | 100.00% | 0.10% |
| RHUMBLINE ADVISERS | 02/13/2026 | 65.03 K | $354.43 K | -5.80% | 0.10% |
| XTX TOPCO LTD | 02/17/2026 | 60.81 K | $331.42 K | 145.16% | 0.09% |
| TBH GLOBAL ASSET MANAGEMENT, LLC | 01/29/2026 | 60.32 K | $328.76 K | 0.00% | 0.09% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 59.24 K | $324.63 K | -0.70% | 0.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 54.69 K | $298.07 K | 100.00% | 0.08% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/17/2026 | 51.42 K | $280.23 K | 18.42% | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 50.00 K | $272.50 K | 0.00% | 0.08% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 49.05 K | $267.34 K | 54.69% | 0.07% |
| JANE STREET GROUP, LLC | 02/12/2026 | 47.43 K | $258.50 K | 43.28% | 0.07% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 46.37 K | $252.72 K | -31.09% | 0.07% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 43.00 K | $234.34 K | 100.00% | 0.07% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 42.84 K | $233.49 K | -64.52% | 0.07% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 41.66 K | $227.05 K | 0.00% | 0.06% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 40.74 K | $222.06 K | 5.30% | 0.06% |
Aura Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 143 institutional investors and hedge funds held shares of Aura Biosciences Inc. The most heavily invested institutionals were:
Medicxi Ventures Management (Jersey) Ltd: 3.04 M
DIMENSIONAL FUND ADVISORS LP: 558,158
Regency Capital Management Inc.\DE: 532,495
VANGUARD FIDUCIARY TRUST CO: 397,160
UBS Group AG: 118,904
Bank of New York Mellon Corp: 99,433
76.19% of Aura Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 54.98 M shares in the last 24 months. This purchase volume represents approximately $311.71 M in transactions.